Peggy Manders

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Antonis C. Antoniou, Amanda B. Spurdle, Olga M. Sinilnikova et al. · The American Journal of Human Genetics · 2008 · 284 citations · Full text

Allelic Variant, Breast Oncology, Breast Cancer Risk +8

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

Anouk Pijpe, Nadine Andrieu, D. F. Easton et al. · BMJ · 2012 · 231 citations · Full text

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer

Nicoline Hoogerbrugge, Peter Bult, Louise M. de Widt-Levert et al. · Journal of Clinical Oncology · 2002 · 145 citations · Full text

Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients

Paul N. Span, Fred C.G.J. Sweep, Erwin T. Wiegerinck et al. · Clinical Chemistry · 2004 · 132 citations · Full text